Black Rock Inc. Fibrogen Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Fibrogen Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,409,650 shares of FGEN stock, worth $16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,409,650
Previous 6,967,918
65.42%
Holding current value
$16 Million
Previous $16.4 Million
86.91%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FGEN
# of Institutions
65Shares Held
34.6MCall Options Held
461KPut Options Held
102K-
Armistice Capital, LLC New York, NY8.5MShares$56.5 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.86MShares$39 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$26 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA3.74MShares$24.9 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.21MShares$14.7 Million0.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $623M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...